TCL Archive Letter to the Editor: NCI Should Continue Supporting Research In Special Populations July 31, 1998
TCL Archive Advisors approve NCI’s revised plan for $104-million proteomics research program. July 8, 2005
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012